Company of the Year: Boston Scientific

Neuromodulation, endoscopy, urology and peripheral interventions businesses are all generating double-digit revenue increases, driving companywide growth to an expected 8% finish for the year.

By Susan Kelly • Dec. 3, 2018

The MedTech Dive Awards of 2018

The awards recognize the industry's top disruptors and newsmakers. These officials and companies are shaking up the medical technology sector and shaping the future.

By MedTech Dive Team • Dec. 3, 2018

Explore the Trendline➔

Top 5 stories from MedTech Dive

From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.

By MedTech Dive staff

FDA's De Novo pathway is about to get a makeover

"Particularly with really low risk devices, it can be challenging both from FDA's perspective and industry's perspective in terms of how much data is needed," Allyson Mullen, an attorney at Hyman, Phelps & McNamara told MedTech Dive.

By Meg Bryant • Dec. 3, 2018

FDA issues draft guidance on blood glucose monitors

The agency said distinguishing between test systems used in healthcare settings and those for use by patients at home will improve product safety and effectiveness of the devices.

By Susan Kelly • Nov. 30, 2018

GE, VA partner to accelerate creation of 3D medical models

The use of software tailored to the medical sector is expected to slash model creation timelines.

By Nick Paul Taylor • Nov. 30, 2018

Canada vows to strengthen device regulation following media probe

More stringent approval requirements and the mandatory publication of clinical data are among the changes being discussed.

By Nick Paul Taylor • Nov. 30, 2018

Why political contributions linked to a little-known hearing aid firm topped medtech giants

Spending connected to Starkey Hearing Technologies surpassed Medtronic, Boston Scientific and Edwards Lifesciences during the 2018 election cycle.

By David Lim • Nov. 29, 2018

Zimmer Biomet recalls spine fusion, bone growth stimulators

The Warsaw, Indiana-based orthopaedic device maker is recalling 1,360 of the devices due to a lack of adequate validation and controls to ensure the final products were clean and free from bacteria and chemical residue.

By Susan Kelly • Nov. 28, 2018

Teva launches EpiPen generic at same price as Mylan's version

Teva's entry could be a threat to Mylan's EpiPen, but the limited supply may hamper the commercial impact.

By Suzanne Elvidge • Nov. 28, 2018

Synaptive recalls system over brain damage risk

A defect is preventing surgeons from accurately seeing the locations of their tools in the brain.

By Nick Paul Taylor • Nov. 28, 2018

5 takeaways amid new scrutiny of FDA medical device oversight

A slate of recent agency actions have paralleled a new investigative series on product safety by the International Consortium of Investigative Journalists. Here are five areas that could be impacted.

By David Lim • Nov. 27, 2018

Pacing leads recalled for potential connector separation

Germany's Oscor is recalling the TB Temporary Bipolar Pacing Leads because the devices could become separated from the external pulse generator.

By Susan Kelly • Nov. 27, 2018

Reprocessor receives FDA clearance for 4 catheters

Innovative Health gained approval to reprocess four catheter brands, two from Medtronic and one each from Johnson & Johnson's Biosense Webster division and Abbott's St. Jude Medical.

By Susan Kelly • Nov. 27, 2018

FDA approves autoinjector version of Genentech's Actemra

The Roche unit is pitching the device as a convenient self-administration option for some users of its blockbuster drug.

By Nick Paul Taylor • Nov. 27, 2018

FDA pitches boosting 510(k) scrutiny, asks Congress for help

The agency wants to move away from device maker reliance on 510(k) predicate devices older than 10 years and gain new authority to quickly impose special controls.

By David Lim • Nov. 26, 2018

Medtronic buys nutrition data startup for diabetes care

Nutrino Health’s services include artificial intelligence tools for personalized analysis of how nutritional intake will affect a person's health.

By Susan Kelly • Nov. 26, 2018

Vectura asthma drug-device combo fails in Phase 3 study

As a result, the pharma will abandon VR475 but carry on with another candidate and three early-stage nebulization programs.

By Andrew Dunn • Nov. 26, 2018

FDA device inspections hit high amid overseas oversight push

The agency conducted 2,952 inspections of medical device manufacturers last year, an increase of 46% over 2007.

By Nick Paul Taylor • Nov. 22, 2018

CMS gives mixed ruling on LivaNova depression device

A big market opportunity awaits the U.K. device maker if Medicare moves to cover the vagus nerve stimulation device for hard-to-treat depression after a required clinical trial.

By Maria Rachal • Nov. 21, 2018

Scientists unveil first 3D images from new whole-body scanner

The scanner combines positron emission tomography and X-ray computed tomography to produce movies that can track drugs as they move through the body.

By Susan Kelly • Nov. 21, 2018

FDA details ramp-up of postmarket device oversight

The agency laid out plans to increase postmarket surveillance of medical devices and previewed details coming next week on how it expects to modernize premarket reviews, especially the 510(k) process.

By Susan Kelly • Nov. 21, 2018

Sandoz and Pear begin selling digital substance use treatment

The FDA called it the first mobile medical app to treat substance use disorders. Pear raised $50 million to fund the commercialization before deciding to pass responsibility for the introduction onto Sandoz.

By Nick Paul Taylor • Nov. 21, 2018

Medtronic posts strong Q2 on diabetes, pain management

Growth in the quarter was led by a 26.2% jump in diabetes group revenue, powered in part by demand for the MiniMed 670G hybrid closed loop insulin pump system in the U.S. market.

By Susan Kelly • Updated Nov. 20, 2018

New Philips ventilator combines two modes in one device

Royal Philips received CE mark approval for a device that allows clinicians to quickly alternate between noninvasive ventilation and high flow therapy used to wean respiratory patients from NIV.

By Susan Kelly • Nov. 20, 2018

FDA plan would ease regulations for prescription drug apps

The agency is seeking public comment on a proposed regulatory framework that would treat most prescription drug apps, including dose calculators, symptom trackers and medication reminders, as promotional labeling.

By Susan Kelly • Nov. 20, 2018